Background Smoking is an important risk factor for several diseases, including different cancers, lung diseases and cardiovascular diseases. About 21% of the Norwegian population are daily smokers.
Interventions for smoking cessation are normally divided into counselling and drug treatment support. In Norway, two prescription drugs are available for use in smoking cessation; varenicline (Champix ® or Chantix ®) and bupropion (Zyban ®). In addition, several options for nicotine replacement therapy are available, such as nicotine-gum, patches and lozenges.
Commision We were commissioned to evaluate the cost-effectiveness of drugs for smoking cessation in a Norwegian setting. The economic evaluation will inform the revised treatment guideline for smoking cessation in primary care.
Main findings
- Compared to no treatment, nicotine replacement therapy, bupropion and varenicline can all be considered cost-effective.
- When the drugs are evaluated relative to each other, varenicline is the most cost-effective alternative.
Preliminary version: HTML in process
- NLM CatalogRelated NLM Catalog Entries
- Cost-effectiveness analysis of clinical smoking cessation interventions in Thailand.[Addiction. 2016]Cost-effectiveness analysis of clinical smoking cessation interventions in Thailand.Tosanguan J, Chaiyakunapruk N. Addiction. 2016 Feb; 111(2):340-50. Epub 2015 Oct 26.
- Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.[Clin Ther. 2012]Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.Athanasakis K, Igoumenidis M, Karampli E, Vitsou E, Sykara G, Kyriopoulos J. Clin Ther. 2012 Aug; 34(8):1803-14. Epub 2012 Jul 20.
- Review Nicotine Replacement Therapy for Smoking Cessation or Reduction: A Review of the Clinical Evidence[ 2014]Review Nicotine Replacement Therapy for Smoking Cessation or Reduction: A Review of the Clinical Evidence. 2014 Jan 16
- Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia.[Tob Control. 2007]Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia.Bertram MY, Lim SS, Wallace AL, Vos T. Tob Control. 2007 Aug; 16(4):255-60.
- Review Which drug to be used in smoking cessation?[Pol Arch Med Wewn. 2008]Review Which drug to be used in smoking cessation?Tønnesen P. Pol Arch Med Wewn. 2008 Jun; 118(6):373-6.
- Cost-Effectiveness of Varenicline, Bupropion and Nicotine Replacement Therapy fo...Cost-Effectiveness of Varenicline, Bupropion and Nicotine Replacement Therapy for Smoking Cessation
Your browsing activity is empty.
Activity recording is turned off.
See more...